Wedge Capital Management L L P Syros Pharmaceuticals, Inc. Transaction History

Wedge Capital Management L L P

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 01, 2019	SELL	$5.5 - $9.75 $458,331 - $812,496	-83,333 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$5.51 - $9.59 $120,911 - $210,442	21,944 Added 35.75%	83,333 $762,000
Q3 2018 Nov 01, 2018	BUY	$9.74 - $12.92 $597,928 - $793,145	61,389 New	61,389 $731,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

Stay updated on Wedge Capital Management L L P with notifications on news.